Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GelStat Corp. stock logo
GSAC
GelStat
$0.00
$0.00
$0.00
$0.00
$247K2.252.69 million shsN/A
Novus Therapeutics, Inc. stock logo
NVUS
Novus Therapeutics
$1.97
-8.8%
$13.23
$4.50
$27.32
$2.83M2.0778,851 shs100,706 shs
SUWN
Sunwin Stevia International
$0.00
$0.00
$0.00
$0.03
$60K-0.531,050 shsN/A
Tower One Wireless Corp. stock logo
TOWTF
Tower One Wireless
$0.04
$0.00
$0.00
$10K0.04N/AN/A
Acerus Pharmaceuticals Co. stock logo
TRLPF
Acerus Pharmaceuticals
$0.22
$0.22
$0.08
$0.34
$56.90M2.65,474 shsN/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GelStat Corp. stock logo
GSAC
GelStat
0.00%0.00%0.00%+33.33%+33.33%
Novus Therapeutics, Inc. stock logo
NVUS
Novus Therapeutics
0.00%+26.25%+0.50%+18.82%-11.01%
SUWN
Sunwin Stevia International
0.00%0.00%0.00%0.00%-96.39%
Tower One Wireless Corp. stock logo
TOWTF
Tower One Wireless
0.00%0.00%0.00%0.00%-99.78%
Acerus Pharmaceuticals Co. stock logo
TRLPF
Acerus Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
GelStat Corp. stock logo
GSAC
GelStat
N/AN/AN/AN/AN/AN/AN/AN/A
Novus Therapeutics, Inc. stock logo
NVUS
Novus Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
SUWN
Sunwin Stevia International
N/AN/AN/AN/AN/AN/AN/AN/A
Tower One Wireless Corp. stock logo
TOWTF
Tower One Wireless
N/AN/AN/AN/AN/AN/AN/AN/A
Acerus Pharmaceuticals Co. stock logo
TRLPF
Acerus Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GelStat Corp. stock logo
GSAC
GelStat
N/AN/AN/AN/A
Novus Therapeutics, Inc. stock logo
NVUS
Novus Therapeutics
N/AN/AN/AN/A
SUWN
Sunwin Stevia International
N/AN/AN/AN/A
Tower One Wireless Corp. stock logo
TOWTF
Tower One Wireless
N/AN/AN/AN/A
Acerus Pharmaceuticals Co. stock logo
TRLPF
Acerus Pharmaceuticals
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GelStat Corp. stock logo
GSAC
GelStat
N/AN/AN/AN/AN/AN/A
Novus Therapeutics, Inc. stock logo
NVUS
Novus Therapeutics
N/AN/AN/AN/A$13.13 per shareN/A
SUWN
Sunwin Stevia International
$35.26M0.00N/AN/A$0.02 per share0.02
Tower One Wireless Corp. stock logo
TOWTF
Tower One Wireless
$8.53M0.00N/AN/AN/ANaN
Acerus Pharmaceuticals Co. stock logo
TRLPF
Acerus Pharmaceuticals
$7.38M7.71N/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GelStat Corp. stock logo
GSAC
GelStat
N/AN/A0.00N/AN/AN/AN/AN/A
Novus Therapeutics, Inc. stock logo
NVUS
Novus Therapeutics
-$16.01M-$21.58N/AN/AN/AN/A-133.49%-30.52%N/A
SUWN
Sunwin Stevia International
-$2.91MN/A0.00N/AN/AN/AN/AN/A
Tower One Wireless Corp. stock logo
TOWTF
Tower One Wireless
-$3.34MN/A0.00N/AN/AN/AN/AN/AN/A
Acerus Pharmaceuticals Co. stock logo
TRLPF
Acerus Pharmaceuticals
-$18.79M-$0.08N/AN/A-254.66%-346.72%-94.54%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
GelStat Corp. stock logo
GSAC
GelStat
N/AN/AN/AN/AN/A
Novus Therapeutics, Inc. stock logo
NVUS
Novus Therapeutics
N/AN/AN/AN/AN/A
SUWN
Sunwin Stevia International
N/AN/AN/AN/AN/A
Tower One Wireless Corp. stock logo
TOWTF
Tower One Wireless
N/AN/AN/AN/AN/A
Acerus Pharmaceuticals Co. stock logo
TRLPF
Acerus Pharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GelStat Corp. stock logo
GSAC
GelStat
N/AN/AN/A
Novus Therapeutics, Inc. stock logo
NVUS
Novus Therapeutics
N/A
18.78
18.78
SUWN
Sunwin Stevia International
N/AN/AN/A
Tower One Wireless Corp. stock logo
TOWTF
Tower One Wireless
N/AN/AN/A
Acerus Pharmaceuticals Co. stock logo
TRLPF
Acerus Pharmaceuticals
0.64
1.35
0.90

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
GelStat Corp. stock logo
GSAC
GelStat
2617.98 million491.29 millionNot Optionable
Novus Therapeutics, Inc. stock logo
NVUS
Novus Therapeutics
71.44 millionN/ANot Optionable
SUWN
Sunwin Stevia International
242199.63 million197.84 millionNot Optionable
Tower One Wireless Corp. stock logo
TOWTF
Tower One Wireless
N/A119.26 million81.13 millionNot Optionable
Acerus Pharmaceuticals Co. stock logo
TRLPF
Acerus Pharmaceuticals
29258.62 millionN/ANot Optionable

NVUS, SUWN, TRLPF, GSAC, and TOWTF Headlines

SourceHeadline
Takeda Pharmaceutical Co. Ltd. ADRTakeda Pharmaceutical Co. Ltd. ADR
wsj.com - February 8 at 10:03 AM
Other OTC Pharmaceuticals - LithuaniaOther OTC Pharmaceuticals - Lithuania
statista.com - September 17 at 1:59 AM
2023 A Big Year For Testosterone: AbbVie And ANI Pharmaceuticals Best Positioned To Benefit2023 A Big Year For Testosterone: AbbVie And ANI Pharmaceuticals Best Positioned To Benefit
seekingalpha.com - January 1 at 9:14 AM
Acerus Reports Second Quarter 2022 Financial ResultsAcerus Reports Second Quarter 2022 Financial Results
financialpost.com - August 9 at 7:47 AM
Acerus Reports Fourth Quarter and Full Year 2021 Financial ResultsAcerus Reports Fourth Quarter and Full Year 2021 Financial Results
financialpost.com - March 15 at 7:47 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

GelStat logo

GelStat

OTCMKTS:GSAC
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.
Novus Therapeutics logo

Novus Therapeutics

NASDAQ:NVUS
Novus Therapeutics, Inc., a specialty pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. Its lead product is OP0201, a surfactant-based nasal aerosol drug-device combination product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). The company also has a foam-based drug delivery technology OP0101 and OP0102 that could be used to deliver drugs into the ear, nose, and sinus cavities. Novus Therapeutics, Inc. is headquartered in Irvine, California.

Sunwin Stevia International

OTCMKTS:SUWN
Sunwin Stevia International, Inc. produces and sells natural sweeteners and other pharmaceutical products primarily in the People's Republic of China. It operates through two segments, Stevioside; and Corporate and Other Pharmaceutical. The company produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components. It offers Steviosin, a low calorie stevia extract for medicinal use; and OnlySweet, a zero calorie, tabletop sweetener to food and drug manufacturers, and ingredient distributor foreign trade companies. The company also produces and sells Metformin, a medication for the treatment of type 2 diabetes. Sunwin Stevia International, Inc. is based in Qufu, China.
Tower One Wireless logo

Tower One Wireless

OTCMKTS:TOWTF
Tower One Wireless Corp. owns, develops, and operates build-to-suit multitenant communications towers in Argentina, Colombia, Mexico, the United States, and internationally. It primarily engages in the leasing of space on communications sites to mobile network operators. The company also provides tower-related services, including site acquisition, zoning and permitting, structural analysis, and construction. Tower One Wireless Corp. was incorporated in 2005 and is headquartered in Bogotá, Colombia.
Acerus Pharmaceuticals logo

Acerus Pharmaceuticals

OTCMKTS:TRLPF
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Elegant vaginal moisturizer, which provides comfort to women suffering from vaginal dryness; and Elegant pH, a pH balanced vaginal product; Gynoflor, an ultra-low dose vaginal estrogen combined with a probiotic for the treatment of vaginal atrophy, restoration of vaginal flora, and treatment of certain vaginal infections; and Tefina, a clinical stage product for women with female sexual dysfunction. Acerus Pharmaceuticals Corporation sells products through its salesforce in Canada; and through a network of licensed distributors in the United States and internationally. The company was formerly known as Trimel Pharmaceuticals Corporation and changed its name to Acerus Pharmaceuticals Corporation in September 2015. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada.